Disclosure of a transparency notification from Aberdeen Group plc

Group 1 - Fagron received a transparency notification from Aberdeen Group plc indicating that its shareholding has fallen below the 3% disclosure threshold due to a disposal of voting securities [8] - As of 13 March 2026, Aberdeen Group plc holds a total of 2,195,403 shares in Fagron, which corresponds to 2.98% of the total voting rights based on 73,668,904 outstanding voting rights [8] - The shares are held through two entities: 1,850,845 shares through abrdn Investment Management Limited and 344,558 shares through abrdn Investments Limited [8] Group 2 - Fagron is a leading global company in pharmaceutical compounding, providing personalized medicine to various healthcare facilities in over 38 countries [3] - The company is based in Nazareth, Belgium, and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR' [4]